SCHEMBL16812014

SCHEMBL16812014

O=C(NC1CCN(Cc2ccc(N3CCC(NC(=O)c4cccc(-c5cccnc5)c4)CC3)nc2)CC1)c1ccc(Cl)c(-c2cccnn2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.77
▸ DRD4 P21917 3/20 0.48
▸ CXCR4 P61073 1/20 0.44
▸ WNT1 P04628 1/20 0.44
▸ DYRK1A Q13627 1/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ DRD2 P14416 2/20 0.43
▸ SLC6A5 Q9Y345 1/20 0.43
▸ RIPK2 O43353 1/20 0.42
▸ PRKAA2 P54646 2/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ SSTR5 P35346 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ IGF1R P08069 1/20 0.41
▸ PRKAB2 O43741 1/20 0.40
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ PRKAG3 Q9UGI9 1/20 0.40
▸ PRKAG2 Q9UGJ0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811980 0.93 SMO (0.79) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16811858 0.93 SMO (0.86) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16811856 0.93 SMO (0.86) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16812020 0.92 SMO (0.77) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16812017 0.92 SMO (0.77) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16812015 0.91 SMO (0.75) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16812001 0.90 SMO (0.77) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16811998 0.90 SMO (0.79) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL16811982 0.90 SMO (0.81) SMODRD4CXCR4WNT1DYRK1A
SCHEMBL15614962 0.89 SMO (0.79) SMODRD4CXCR4WNT1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885DRD4 4828/4885CXCR4 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback